Evidence map›Paper›PMID 27642494›Full record

ArticleOxidative medicine and cellular longevity2016

Oxidation-Reduction Potential as a Biomarker for Severity and Acute Outcome in Traumatic Brain Injury.

Kimberly B Bjugstad, Leonard T Rael, Stewart Levy, Matthew Carrick, Charles W Mains, Denetta S Slone, David Bar-Or

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex.Translational research : the journal of laboratory and clinical medicine · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kimberly B BjugstadDepartment of Trauma Research, Swedish Medical Center, Englewood, CO 80113, USA.ORCID 0000-0002-0473-5413
Leonard T RaelDepartment of Trauma Research, Swedish Medical Center, Englewood, CO 80113, USA.ORCID 0000-0003-3282-7072
Stewart LevyInterMountain Neurosurgery, St. Anthony Hospital, Lakewood, CO 80228, USA.
Matthew CarrickMedical Center of Plano, Plano, TX 75075, USA.
Charles W MainsDepartment of Trauma Research, St. Anthony Hospital, Lakewood, CO 80228, USA; Department of Biomedical Sciences, Rocky Vista University, Aurora, CO 80134, USA; Penrose-St. Francis Health Services, Colorado Springs, CO 80907, USA.
Denetta S SloneDepartment of Trauma Research, Swedish Medical Center, Englewood, CO 80113, USA; Department of Biomedical Sciences, Rocky Vista University, Aurora, CO 80134, USA.
David Bar-OrDepartment of Trauma Research, Swedish Medical Center, Englewood, CO 80113, USA; Department of Trauma Research, St. Anthony Hospital, Lakewood, CO 80228, USA; Department of Biomedical Sciences, Rocky Vista University, Aurora, CO 80134, USA; Penrose-St. Francis Health Services, Colorado Springs, CO 80907, USA.ORCID 0000-0002-3685-314X
Rocky Vista University · USSwedish Medical Center · USPlano Cancer Institute · USSt. Anthony Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are few reliable markers for assessing traumatic brain injury (TBI). Elevated levels of oxidative stress have been observed in TBI patients. We hypothesized that oxidation-reduction potential (ORP) could be a potent biomarker in TBI. Two types of ORP were measured in patient plasma samples: the static state of oxidative stress (sORP) and capacity for induced oxidative stress (icORP). Differences in ORP values as a function of time after injury, severity, and hospital discharge were compared using ANOVAs with significance at p ≤ 0.05. Logit regression analyses were used to predict acute outcome comparing ORP, Injury Severity Score (ISS), Abbreviated Injury Scale (AIS), and Glasgow Coma Scale (GCS). Antioxidant capacity (icORP) on day 4 was prognostic for acute outcomes (p < 0.05). An odds ratio of 4.08 was associated with poor acute outcome when icORP > 7.25 μC. IcORP was a better predictor than ISS, AIS, or GCS scores. sORP increased in those with the highest ISS values (p < 0.05). Based on these findings ORP is useful biomarker for severity and acute outcome in TBI patients. Changes in ORP values on day 4 after injury were the most prognostic, suggesting that patients' response to brain injury over time is a factor that determines outcome.

Indexed as

Oxidative StressAcute DiseaseBiomarkersBrain Injuries, TraumaticColoradoFemaleGlasgow Coma ScaleHumansInjury Severity ScoreLength of StayLogistic ModelsMaleMiddle AgedOdds RatioOxidation-ReductionPatient DischargeBiomarkers

Identifiers

PMID27642494
PMCPMC5014948
OpenAlexW2514673486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.